Date: 2015-08-18
Type of information: Collaboration agreement
Compound:
Company: Helix (USA - CA) Mayo Clinic (USA - MN) Laboratory Corporation of America® Holdings (LabCorp) (USA - NC)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On August 18, 2015, Helix, a new company created by Illumina to empower consumers to discover insights into their own genomes, announced a collaboration with Laboratory Corporation of America® Holdings (LabCorp®). Ther partners will develop and offer innovative analysis and interpretation services, initially focused on medically actionable genetic conditions, to consumers through Helix\'s platform. Helix expects that other partners will develop applications focused on areas such as genealogy, fitness or wellness, and inherited traits to enable insights related to an individual\'s genetics. To support its partners, Helix will establish one of the world\'s largest next-generation sequencing labs and a secure and protected database, all designed in accordance with CLIA, CAP, and HIPAA guidelines. Individuals will be able to control how their data is accessed through a robust and granular consent process.
Financial terms:
Latest news:
